These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 23980194

  • 1. E258K HCM-causing mutation in cardiac MyBP-C reduces contractile force and accelerates twitch kinetics by disrupting the cMyBP-C and myosin S2 interaction.
    De Lange WJ, Grimes AC, Hegge LF, Spring AM, Brost TM, Ralphe JC.
    J Gen Physiol; 2013 Sep; 142(3):241-55. PubMed ID: 23980194
    [Abstract] [Full Text] [Related]

  • 2. The W792R HCM missense mutation in the C6 domain of cardiac myosin binding protein-C increases contractility in neonatal mouse myocardium.
    Mertens J, De Lange WJ, Farrell ET, Harbaugh EC, Gauchan A, Fitzsimons DP, Moss RL, Ralphe JC.
    J Mol Cell Cardiol; 2024 Oct; 195():14-23. PubMed ID: 39059462
    [Abstract] [Full Text] [Related]

  • 3. Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue.
    de Lange WJ, Grimes AC, Hegge LF, Ralphe JC.
    J Gen Physiol; 2013 Jan; 141(1):73-84. PubMed ID: 23277475
    [Abstract] [Full Text] [Related]

  • 4. The HCM-linked W792R mutation in cardiac myosin-binding protein C reduces C6 FnIII domain stability.
    Smelter DF, de Lange WJ, Cai W, Ge Y, Ralphe JC.
    Am J Physiol Heart Circ Physiol; 2018 Jun 01; 314(6):H1179-H1191. PubMed ID: 29451820
    [Abstract] [Full Text] [Related]

  • 5. The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position.
    Mun JY, Kensler RW, Harris SP, Craig R.
    J Mol Cell Cardiol; 2016 Feb 01; 91():141-7. PubMed ID: 26718724
    [Abstract] [Full Text] [Related]

  • 6. A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction.
    Kuster DW, Govindan S, Springer TI, Martin JL, Finley NL, Sadayappan S.
    J Biol Chem; 2015 Feb 27; 290(9):5855-67. PubMed ID: 25583989
    [Abstract] [Full Text] [Related]

  • 7. Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.
    Mamidi R, Gresham KS, Li A, dos Remedios CG, Stelzer JE.
    J Mol Cell Cardiol; 2015 Aug 27; 85():262-72. PubMed ID: 26100051
    [Abstract] [Full Text] [Related]

  • 8. In vivo definition of cardiac myosin-binding protein C's critical interactions with myosin.
    Bhuiyan MS, McLendon P, James J, Osinska H, Gulick J, Bhandary B, Lorenz JN, Robbins J.
    Pflugers Arch; 2016 Oct 27; 468(10):1685-95. PubMed ID: 27568194
    [Abstract] [Full Text] [Related]

  • 9. Cardiac myosin binding protein-C phosphorylation accelerates β-cardiac myosin detachment rate in mouse myocardium.
    Tanner BCW, Previs MJ, Wang Y, Robbins J, Palmer BM.
    Am J Physiol Heart Circ Physiol; 2021 May 01; 320(5):H1822-H1835. PubMed ID: 33666504
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin.
    McNamara JW, Singh RR, Sadayappan S.
    Proc Natl Acad Sci U S A; 2019 Jun 11; 116(24):11731-11736. PubMed ID: 31142654
    [Abstract] [Full Text] [Related]

  • 15. Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy.
    Kuster DWD, Lynch TL, Barefield DY, Sivaguru M, Kuffel G, Zilliox MJ, Lee KH, Craig R, Namakkal-Soorappan R, Sadayappan S.
    Cardiovasc Res; 2019 Dec 01; 115(14):1986-1997. PubMed ID: 31050699
    [Abstract] [Full Text] [Related]

  • 16. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
    O'Leary TS, Snyder J, Sadayappan S, Day SM, Previs MJ.
    J Mol Cell Cardiol; 2019 Feb 01; 127():165-173. PubMed ID: 30550750
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
    Stöhr A, Friedrich FW, Flenner F, Geertz B, Eder A, Schaaf S, Hirt MN, Uebeler J, Schlossarek S, Carrier L, Hansen A, Eschenhagen T.
    J Mol Cell Cardiol; 2013 Oct 01; 63():189-98. PubMed ID: 23896226
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.